Floatz logo

Trans-Cinnamaldehyde

Chemotherapy-induced Peripheral Neuropathy

Universitaire Ziekenhuizen KU LeuvenN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

29 Active assets in the Chemotherapy-induced Peripheral Neuropathy cohort.

Asset / SponsorPhaseRating
Pregabalin
University of Rochester
Phase 4BB
Omeprazole
Aya Mohamed Sadek Elsaid
Phase 3BB
LIDOCAINE
Hospital Ambroise Paré Paris
Phase 2BB
Mecobalamin
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3B
Vitamin B6
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3B

View all 46 →

Same molecule, other indications

Trans-Cinnamaldehyde is also rated in:

neuralgiaDormant
D
Indicative ·
30 / 100
View asset →
PainDormant
D
Indicative ·
30 / 100
View asset →
PruritusDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →